Oracle CEO Safra Catz to Sell $289M in ORCL Stock After Options Exercise

Oracle Corp Form 144 filing reveals CEO Safra Catz's planned sale of 1,410,547 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $289.79 million.

Rhea-AI Filing Summary

Oracle Corp Form 144 filing reveals CEO Safra Catz's planned sale of 1,410,547 shares of common stock through Fidelity Brokerage Services, with an aggregate market value of $289.79 million. The shares were acquired through stock options exercise on June 23, 2025.

Key details of the transaction:

• Shares to be sold represent approximately 0.05% of Oracle's total outstanding shares (2.81 billion)
• Planned execution date: June 23, 2025
• Trading venue: NYSE

Notable previous transaction: Catz sold 2,284,371 shares for gross proceeds of $474.22 million on June 20, 2025. This Form 144 represents a declaration of intention to sell securities, filed in compliance with SEC Rule 144 for insider sales. The filing indicates the seller has no knowledge of undisclosed material adverse information about Oracle's operations.

Positive

• None.

Negative

• CEO Safra Catz plans to sell 1.41M shares worth $289.8M, following recent sale of 2.28M shares worth $474.2M in June 2025, indicating significant insider selling activity from key executive

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ORCL shares is Safra Catz planning to sell according to the June 2025 Form 144?

According to the Form 144 filing dated June 28, 2025, Oracle CEO Safra Catz plans to sell 1,410,547 shares of ORCL common stock through Fidelity Brokerage Services LLC, with an aggregate market value of $289,786,866.

What was Safra Catz's previous ORCL stock sale in the past 3 months?

The filing shows that Safra Catz sold 2,284,371 shares of ORCL common stock on June 20, 2025, generating gross proceeds of $474,221,028.

How did Safra Catz acquire the ORCL shares being sold in this Form 144?

According to the filing, the shares were acquired through a Stock Options Exercise from the Issuer (Oracle) on June 23, 2025, with payment made in cash on the same date.

What percentage of ORCL's outstanding shares does Safra Catz's proposed sale represent?

The proposed sale of 1,410,547 shares represents approximately 0.05% of Oracle's total outstanding shares, which the filing indicates is 2,808,833,000 shares.

When does Safra Catz plan to execute the ORCL stock sale?

According to the Form 144 filing, the approximate date of sale is indicated as June 23, 2025, and the shares will be sold on the NYSE (New York Stock Exchange).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2025 - 04:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001205005
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ORACLE CORP
SEC File Number	001-35992
Address of Issuer	2300 ORACLE WAY AUSTIN TEXAS 78741
Phone	(737) 867-1000
Name of Person for Whose Account the Securities are To Be Sold	CATZ SAFRA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Fidelity Brokerage Services LLC 245 Summer Street Boston MA 02110	1410547	289786866.00	2808833000	06/23/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/23/2025	Stock Options Exercise	Issuer			1410547	06/23/2025	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SAFRA Catz C/O Oracle corp 2300 ORACLE WAY Austin TX 78741	Common stock	06/20/2025	2284371	474221028.00

144: Remarks and Signature

Remarks	shares are being sold from HARBOR ISLAND JOINT REV TR U/A 10/7/21
Date of Notice	06/23/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/25/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Audrey Skillern as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Safra Catz
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)